![Denil Shekhat](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Denil Shekhat
Directeur/Bestuurslid bij
MIRA PHARMACEUTICALS, INC.
Vermogen: 21 192 $ op 30-06-2026
Profiel
Dr. Denil N.
Shekhat, MD, is an Independent Director at MIRA Pharmaceuticals, Inc. He is on the Board of Directors at MIRA Pharmaceuticals, Inc. He received his undergraduate degree from Bowdoin College and a doctorate degree from The University of Tennessee Health Science Center.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-06-2026 | 22.378 ( 0,05% ) | 21 192 $ | 30-06-2026 |
Actieve functies van Denil Shekhat
| Bedrijven | Functie | Begin |
|---|---|---|
| MIRA PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 13-03-2024 |
Opleiding van Denil Shekhat
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
1
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Tennessee Health Science Center
 The University of Tennessee Health Science Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIRA Pharmaceuticals, Inc.
 MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
